ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $533,000 | -28.1% | 22,889 | -3.7% | 0.00% | -33.3% |
| Q3 2021 | $741,000 | -4.6% | 23,757 | +7.6% | 0.00% | 0.0% |
| Q2 2021 | $777,000 | -18.6% | 22,084 | -18.4% | 0.00% | -25.0% |
| Q1 2021 | $954,000 | -5.9% | 27,063 | +0.1% | 0.00% | 0.0% |
| Q4 2020 | $1,014,000 | +66.0% | 27,028 | +47.7% | 0.00% | +100.0% |
| Q3 2020 | $611,000 | +32.3% | 18,303 | +5.0% | 0.00% | 0.0% |
| Q2 2020 | $462,000 | -80.7% | 17,438 | -81.5% | 0.00% | -75.0% |
| Q4 2019 | $2,394,000 | -37.9% | 94,187 | -51.2% | 0.01% | -42.9% |
| Q3 2019 | $3,857,000 | -36.9% | 192,850 | +1.8% | 0.01% | -36.4% |
| Q2 2019 | $6,109,000 | +771.5% | 189,500 | +770.4% | 0.02% | +633.3% |
| Q1 2019 | $701,000 | – | 21,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |